Prism Medico & Pharmacy Share Price

Prism Medico & Pharmacy

CMP as on22-Oct-21 15:29

₹ 6.50
-0.18 -2.69%

Open

₹ 6.70

Turnover (lac)

Prev. Close

₹ 6.68

Day's Vol (shares)

₹ 16,649

Day's Range

₹ 6.33
₹ 6.98

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 12-Aug-2021 - -
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/08/2021 inter alia to consider and approve To consider and transact the following business: 1. To consider and approve the appointment of Mr. Ramandeep Singh (DIN: 07896086) as an Additional Independent Non-executive Director. 2. To consider and accept the resignation of Mr. Jimit Jintendra Trivedi (DIN: 08585697) from the directorship of the company. 3. To fix the Date Time and Venue for convening 19th Annual General Meeting of the Members of the Company and approve the Draft Notice for the same. 4. To consider and approve the Draft Directors Report for the F.Y. 2020-21 for the purpose of 19th Annual General Meeting. 5. To approve the Book-closure dates as per regulation 42 of the SEBI (LODR) Regulations 2015 for the purpose of 19th Annual General Meeting of the Company. 6. To appoint the Scrutinizer for 19th Annual General Meeting. 7. Any other business with the permission of chair. we wish to inform you that the Board of Directors of the Company at their meeting held on Friday, 20th August 2021 at 10.00 a.m concluded at 12:00 noon. Following transactions were considered and approved are attached herewith. Board of Directors in their meeting held on Friday, 20th August 2021 hereby submit requite disclosure as per regulation 30 of Schedule III of SEBI (LODR) Regulations, 2015. Kindly take the same on your records. (As per BSE Announcement Dated on 20/8/2021)
Board Meeting - 12-Jul-2021 - -
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/07/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 read with regulation 33 of SEBI (LODR) Regulations, 2015, we hereby inform you that the meeting of Board of Directors of the Company is scheduled to be held on Monday, 19th July 2021 at 11.00 a.m. to consider and transact the following business: 1. To consider and approve the un-audited Financial Results for the quarter ended June 30, 2021. 2. Any other business with the permission of chair. With reference to the above captioned subject, we wish to inform you that the Board of Directors of the Company at their meeting held on Friday, 09th July 2021 at 10.00 a.m concluded at 10.30 p.m. took note of resignation of Mr. Sudhanshu Srivastav as an Executive Director from the Board of the Company and all the Committees there-under in which he is a member, with effect from 29th June 2021 due to personal commitments and pre-occupations. (As per BSE Announcement Dated on 9/7/2021) With reference to the above captioned subject, we wish to inform you that the Board of Directors of the Company at their meeting held on Monday, 19th July 2021 at 11.00 a.m concluded at 11.30 a.m. . Following transactions were approved: 1. Un-Audited Financial Results for the quarter ended on 30th June 2021. 2. Limited Review Report from the auditor for the quarter ended on 30th June 2021. (As Per BSE Announcement Dated on 19.07.2021)
Board Meeting - 19-Apr-2021 - -
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/04/2021 ,inter alia, to consider and approve To consider and discuss the following items: 1. To consider and approve the audited Financial Results for the year ended March 31, 2021. 2. To consider and approve the appointment of M/s. M R Chechi & Associates, Company Secretaries, Chandigarh as Secretarial Auditor of the company for F.Y. 2020-21. 3. To consider and approve the resignation of M/s. S Harpreet & Associates, Chartered Accountants, Punjab as Internal Auditor of the company for F.Y. 2020-21. 4. To consider and approve the appointment of M/s. N. Kumar & Company, Chartered Accountants, Punjab as Internal Auditor of the company for F.Y. 2020-21. 5. Any other matter with the permission of the Chair. The Board of Directors of the Company at their meeting held on Tuesday, 27th April 2021 at 11.30 a.m concluded at 12.30 p.m. Following transactions were approved: 1. Audited Standalone Financial Results for the quarter and year ended on 31st March, 2021. 2. Auditors Report on Audited Standalone Financial Results for the year ended on 31st March, 2021. 3. Declaration for Un-Modified Opinion with Audit Report on Audited Standalone Financial Results for the quarter and year ended on 31st March, 2021. 4. The appointment of M/s. M R Chechi & Associates, Company Secretaries, Chandigarh as Secretarial Auditor of the company for F.Y. 2020-21. 5. The resignation of M/s. S Harpreet & Associates, Chartered Accountants, Punjab as Internal Auditor of the company for F.Y. 2020-21. 6. The appointment of M/s. N. Kumar & Company, Chartered Accountants, Punjab as Internal Auditor of the company for F.Y. 2020-21. We are enclosing herewith: 1. Audited Financial Results for the quarter and year ended on 31st March, 2021. 2. Auditors Report on Audited Financial Results for the quarter and year ended on 31st March, 2021. 3. Declaration for Un-Modified Opinion with Audit Report on Audited Financial Results for the quarter and year ended on 31st March, 2021. (AS Per BSE Announcement Dated on 27.04.2021)
Board Meeting - 04-Feb-2021 - -
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2021 ,inter alia, to consider and approve In continuation to the earlier intimation of meeting of Board of Directors of the Company to be held on Friday, 12/02/2021 at 3.00 p.m., we would like to inform you that there is a clerical error in point no. 1 in which we mentioned Quarter ended 31st December 2021 instead of Quarter ended 31st December 2020. Please consider it as Quarter ended 31st December 2020. we wish to inform you that the Board of Directors of the Company at their meeting held on Friday, 12th February 2021 at 03.00 p.m concluded at 03.30 p.m. Following transactions were approved: 1. Un-Audited Financial Results for the quarter ended on 31st December 2020. 2. Limited Review Report from the auditor for the quarter ended on 31st December 2020. 3. Appointment of Mrs. Simmi Chhabra as an Additional Director (Independent-Non Executive Woman Director) on the Board of the Company for a term of 5 years, w.e.f February 12, 2021, subject to shareholders approval. (AS Per BSE Announcement Dated on 12.02.2021)
Board Meeting - 02-Nov-2020 - -
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2020 ,inter alia, to consider and approve 1.To consider and approve the un-audited Financial Results for the quarter and half year ended 30th September, 2020. With reference to the above captioned subject, we wish to inform you that the Board of Directors of the Company at their meeting held on Tuesday, 10th November 2020 at 03.00 p.m concluded at 03.30 p.m. Transactions approved are hereby attached. (As Per BSE Announcement dated on 10.11.2020)
Open ZERO Brokerage Demat Account